Jacob D Bitran

Author PubWeight™ 7.54^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.	Biol Blood Marrow Transplant	2009	1.22
2	Erlotinib has moderate single-agent activity in chemotherapy-naïve castration-resistant prostate cancer: final results of a phase II trial.	Urology	2009	0.94
3	Efficacy and safety of clofarabine in relapsed and/or refractory non-Hodgkin lymphoma, including rituximab-refractory patients.	Cancer	2010	0.87
4	Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).	Biol Blood Marrow Transplant	2008	0.79
5	Erlotinib in lung cancer.	N Engl J Med	2005	0.75
6	A phase II pilot trial investigating the efficacy and activity of single agent granulocyte macrophage colony-stimulating factor as maintenance approach in castration - resistant prostate cancer patients responding to chemotherapy.	Avicenna J Med	2011	0.75
7	Chronic lymphocytic leukemia: to transplant or not to transplant... that is the question?	J Clin Oncol	2005	0.75
8	Thalidomide and dexamethasone for newly diagnosed multiple myeloma: is this really the standard of care?	J Clin Oncol	2006	0.75
9	Disclosing the cancer diagnosis:the myth and the truth.	J Clin Oncol	2010	0.75
10	Mitomycin-C/5-fluorouracil/leucovorin and hyperfractionated radiation therapy for rectal carcinoma: a phase II study with long-term follow-up.	Clin Colorectal Cancer	2007	0.75